EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review

Mohamed A Satti iD, Carmen Paredes Saenz, Rubin Raju, Sierra Cuthpert, Abed Kanzy, Sina Abhari, John Hebert Iii, Frederico G Rocha

Case Reports in Obstetrics and Gynecology · 2016 · 2016 · 1-6

DOI: 10.1155/2016/9803250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Obstetrics and Gynecology, 2016. Verfasst von Mohamed A Satti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Hurley Medical Center/Michigan State University College of Human Medicine, Flint, MI 48503, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Uterine leiomyomas, also called uterine fibroids or myomas, are the most common pelvic tumors in women. They are very rarely the cause of acute complications. However, when complications occur they cause significant morbidity and mortality. Thromboembolic disease has been described as a rare complication of uterine leiomyomas. DVT is a serious illness, sometimes causing death due to acute PE. Cases . We report a case series of 3 patients with thromboembolic disease associated with uterine leiomyoma at Hurley Medical Center, Flint, Michigan, during 2015 and conduct a literature review on the topic. A literature search was conducted using Medline, PubMed, and PMC databases from 1966 to 2015.

Conclusion

The uterine leiomyoma is a very rare cause of PE and only few cases have been reported. DVT secondary to uterine leiomyoma should be considered in a female presenting with abdominal mass and pelvic pressure, if there is no clear common cause for her symptoms. Thromboembolic disease secondary to large uterine leiomyoma should be treated with acute stabilization and then hysterectomy. Prophylactic anticoagulation would be beneficial for lowering the risk of VTE in patients with large uterine leiomyoma.

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Hurley Medical Center/Michigan State University College of Human Medicine, Flint, MI 48503, USA.
  • Department of Internal Medicine, Hurley Medical Center/Michigan State University College of Human Medicine, Flint, MI 48503, USA.

ORCID-Profile: Mohamed A Satti

Zitieren

APA

Satti, M. A., Paredes Saenz, C., Raju, R., Cuthpert, S., Kanzy, A., Abhari, S., Hebert Iii, J., & Rocha, F. G. (2016). Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review. Case Reports in Obstetrics and Gynecology, 2016, 1-6. https://doi.org/10.1155/2016/9803250

Vancouver

Satti MA, Paredes Saenz C, Raju R, Cuthpert S, Kanzy A, Abhari S, et al. Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review. Case Reports in Obstetrics and Gynecology. 2016;2016:1-6. doi:10.1155/2016/9803250

BibTeX
@article{Satti2016,
  author = {Satti, Mohamed A and Paredes Saenz, Carmen and Raju, Rubin and Cuthpert, Sierra and Kanzy, Abed and Abhari, Sina and Hebert Iii, John and Rocha, Frederico G},
  title = {Should Prophylactic Anticoagulation Be Considered with Large Uterine Leiomyoma? A Case Series and Literature Review},
  journal = {Case Reports in Obstetrics and Gynecology},
  year = {2016},
  volume = {2016},
  pages = {1--6},
  doi = {10.1155/2016/9803250}
}
Kostenlos starten →